7Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
8Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
9Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
10Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
1Stephen GJ, Robert CJ. Critical assessment of issues applicable to development of antimicrobial susceptibility testing breakpoints. J Clin Microbiol, 2011,49 : S5-S10.
2Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis, 2002, 35:982-988.
3Murry PR, Jones R, Novick W. Analysis of clinical predictive value of quantitative susceptibility tests with eefotaxime. Abstr. 23rd conf. Antimicrob Agents Chemother. Abstr, 1983,545 : 182.
4Paul CS, Matthew JB. Optimizing antimicrobial susceptibility test reporting. J Clin Microbiol,2011, 49 : S15-S19.
5Dary--VD, Stephen- MB. The clinical predicti lue (or lake thereof) of the results in vitro antimicrobial susceptibility tests. J Clin Microbiol, 2011, 49 : S11-S14.
